Search

everythinglearnresearchcommunity

for

Search:↓

Merkel cell carcinoma is most likely to recur within two years of diagnosis, and factors like immune suppression, being over 75, and male sex increase this risk.

The FDA approved a new Pfizer drug for hair loss in teens.

DM and AA may share a common cause.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

Metformin, a diabetes drug, may also help fight cancer, but more research is needed to understand how.

Combining calcipotriol with mometasone is more effective for treating alopecia areata than using mometasone alone.

Ritlecitinib effectively improves hair regrowth and physician satisfaction in severe alopecia areata over time.

Most patients with rheumatoid arthritis continued methotrexate treatment over two years, but those who stopped and restarted experienced more side effects and less improvement.

LED light therapy at 863 nm wavelength can slow down skin tumor growth and reduce inflammation in mice.

Cancer prevention has advanced significantly, with some strategies proving successful.

Recombinant thrombomodulin can effectively treat severe complications in Cronkhite-Canada syndrome.

Microneedling with minoxidil, platelet-rich plasma, and mesotherapy improves hair growth significantly.

Methotrexate and vitamin D3 are potentially more effective and safer than triamcinolone for treating localized alopecia areata.

Inhibiting mTORC2 can reduce DNA repair and increase cancer cell death, suggesting potential for targeted brain cancer treatments.

Melanoma's complexity requires personalized treatments due to key genetic mutations and tumor-initiating cells.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

Tofacitinib effectively treated severe hair loss in a patient who didn't respond to other treatments.

A comprehensive approach to educating patients and managing side effects is crucial for improving adherence to multiple sclerosis treatments and patient quality of life.

Patient-derived melanocytes can potentially treat vitiligo by restoring skin pigmentation.

Methotrexate treatment often causes hair loss.

Monitor for early signs of azathioprine toxicity and check blood counts regularly.

A cancer patient died from a severe skin reaction after taking the drug cetuximab.

Mitotane changes steroid breakdown, affecting cortisol availability.

Tumor immunotherapy can cause hair loss by disrupting hair follicle immunity.

Upadacitinib may help regrow hair in children with alopecia areata and is generally safe.

Adverse events from vismodegib can be managed effectively to ensure optimal treatment.